About this trial
The objective of this clinical trial is to evaluate the effectiveness of pelvic floor therapy for the management of erectile dysfunction and premature ejaculation in patients with erectile dysfunction and premature ejaculation. The main question to answer is:
What is the effectiveness of pelvic floor therapy (electrostimulation, biofeedback, and therapeutic exercise) for the treatment of patients with erectile dysfunction and or premature ejaculation?
Patients will:
* Have an initial consultation of pelvic floor rehabilitation before therapy. * Be given pelvic floor therapy. * Have a secondary consultation of pelvic floor rehabilitation after therapy.
Three intervention groups will be included: Group 1: Patients with premature ejaculation Group 2: Patients with erectile dysfunction Group 3: Patients with erectile dysfunction and premature ejaculation.
Eligibility criteria
Qualifiers
Men over 18 years of age
Erectile dysfunction or premature ejaculation for at least 6 months
Sexual activity with a heterosexual partner at least once a week
Signing of informed consent before the start of the study
Disqualifiers
Pharmacological treatment for erectile dysfunction or premature ejaculation in the last 3 months
Erection Hardness Score (EHS) greater than 3 for patients with erectile dysfunction
History of hypogonadism or suspected hypogonadism due to Aging Males Symptoms (AMS) score greater than 36 for patients with erectile dysfunction
History of pelvic radiotherapy
Trial design
Treatments tested in this trial
- Therapeutic exercises
- Perineal electromyographic biofeedback
- Electrical stimulation
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.